Author | Tony Berberabe, MPH

Articles

JNJ-4528 Continues to Show Durable Responses in Relapsed/Refractory Multiple Myeloma

June 07, 2020

The CAR T-cell therapy continued to demonstrate deep and durable responses in heavily pretreated patients with relapsed/refractory multiple myeloma.